FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:869-870 August 21, 2008 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Frew, A. J. PubMed Citation

To the Editor: In his discussion of allergic rhinitis and the clinical use of sublingual immunotherapy, Frew (May 22 issue)¹ reports that the adverse effects of such therapy have been limited mainly to the oral cavity, with only a few cases of anaphylaxis reported. To our knowledge, the studies whose results have been published so far did not look into the incidence of eosinophilic esophagitis with sublingual immunotherapy. Eosinophilic esophagitis is an emerging worldwide disease of unknown cause that mimics gastroesophageal reflux disease and can lead to esophageal narrowing and stricture.² The majority of patients with the condition have evidence . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.